*

Value in Health Supplement

Personalized Medicine and Role of Health Economics and Outcomes Research: Applications, Emerging Trends, and Future Research

Value in Health Ranking

* 2016 Impact Factor:
(© 2017 Journal Citation Report)
4.235
(11% increase from 2015!)

5–Year Impact Factor:
4.491

3rd out of 77 journals in health policy and services (social sciences)
7th out of 347 journals in economics (social sciences)
8th out of 90 journals in health care sciences and services

Value in Health
iPad® & iPhone® App
Value in Health Smartphone App

Services for Authors

Value in Health Smartphone App

Abstracts for all podium and poster research presentations given at the ISPOR 2018 will be published in the Value in Health ((Volume 21, Suppl 1). This issue of Value in Health will be available to ISPOR members and ISPOR 2018 registrants online at: www.ispor.org/valueinhealth_index.asp in June 2018.

 

THEMED SECTION: Rare Diseases

 

Editorial

 

Rare Diseases: Addressing the Challenges in Diagnosis, Drug Approval, and Patient Access
Kati Copley-Merriman

 

Articles

Challenges in Research and Health Technology Assessment of Rare Disease Technologies: Report of the ISPOR Rare Disease Special Interest Group
Sandra Nestler-Parr, Daria Korchagina, Mondher Toumi, Chris L. Pashos, Christopher Blanchette, Elizabeth Molsen-David, Thomas Morel, Steven Simoens, Zoltán Kaló, Ruediger Gatermann, William Redekop

 

The Problem of Rarity: Estimation of Prevalence in Rare Disease
Stéphane Auvin, John Irwin, Paul Abi-Aad, Alysia Battersby

 

Clinical Outcome Assessments: Use of Normative Data in a Pediatric Rare Disease
Dawn Phillips, Beth Leiro

Economic Modelling Considerations for Rare Diseases
Isobel Pearson, Ben Rothwell, Andrew Olaye, Christopher Knight

Budgetary Impact and Cost Drivers of Drugs for Rare and Ultra-Rare Diseases
Michael Schlander, Charalabos-Markos Dintsios, Afschin Gandjour

Can Severity Outweigh Smaller Numbers? A Deliberative Perspective from Canada
Monica Magalhaes

Societal Preferences for Funding Orphan Drugs in the United Kingdom: An Application of Person Trade-Off and Discrete Choice Experiment Methods
Siobhan Bourke, Catrin Plumpton, Dyfrig Hughes

Evaluating and Valuing Drugs for Rare Conditions: No Easy Answers
Dan Ollendorf, Richard Chapman, Steven D. Pearson

Patient Access to Medicines for Rare Diseases in European Countries
Andreja Deticek, Igor Locatelli, Mitja Kos

 

ECONOMIC EVALUATION

 

Cost Effectiveness of a Technology-Facilitated Depression Care Management Adoption Model in Safety-Net Primary Care Patients with Type 2 Diabetes
Joel W. Hay, Pey-Jiuan Lee, Haomiao Jin, Jeffrey Guterman, Sandra Gross-Schulman Kathleen Ell, Shinyi Wu

 

The Development of the Guide to Economic Analysis and Research (GEAR) Online Resource for Low- and Middle-Income Countries' Health Economics Practitioners: A Commentary
Chiaki Urai Adeagbo, Waranya Rattanavipapong, Lorna Guinness, Yot Teerawattananon

 

METHODOLOGY

 

Setting the Boundaries for Economic Evaluation: Investigating Time Horizon and Family Effects in the Case of Postnatal Depression
Jemimah Ride

 

PATIENT-REPORTED OUTCOMES

 

Measurement Equivalence of Patient-Reported Outcome Measure Response Scale Types Collected Using Bring Your Own Device Compared to Paper and a Provisioned Device: Results of a Randomized Equivalence Trial
Bill Byrom, Helen Doll, Willie Muehlhausen, Emuella Flood, Cater Cassedy, Bryan McDowell, Jeremy Sohn, Kyle Hogan, Ryan Belmont, Barbara Skerritt, Marie McCarthy

 

Personal Income Before and After Diagnosis of Multiple Sclerosis
Erik Landfeldt, Anna Castelo-Branco, Axel Svedbom, Emil Löfroth, Andrius Kavaliunas, Jan Hillert

 

PREFERENCE-BASED ASSESSMENTS

 

Handling Data Quality Issues to Estimate the Spanish EQ-5D-5L Value Set Using a Hybrid Interval Regression Approach
Juan M. Ramos-Goñi, Benjamin M. Craig, Mark Oppe, Yolanda Ramallo-Fariña, Jose Luis Pinto-Prades, Nan Luo, Oliver Rivero-Arias

Challenges in Valuing Temporary Health States for Economic Evaluation: A Review of Empirical Applications of the Chained Time Trade-Off Method
Julija Stoniute, David John Mott, Jing Shen

 

Prediction of Health Utility Scores in Patients with Chronic Hepatitis C Using the Chronic Liver Disease Questionnaire-Hepatitis C Version (CLDQ-HCV)
Maria Stepanova, Issah Younossi, Andrei Racila, Zobair M. Younossi

 

Mothers’ Preferences and Willingness to Pay for Human Papillomavirus Vaccination for Their Daughters: A Discrete Choice Experiment in Hong Kong
Carlos K.H. Wong, Kenneth K.C. Man, Patrick Ip, Mike Kwan, Sarah M. McGhee

 

– denotes Editor’s Choice Articles – Limited free access online at www.valueinhealthjournal.com

Past Issues

Volume 21 Issue 3 (March 2018)

Volume 21 Issue 2 (February 2018)

Volume 21 Issue 1 (January 2018)

Manuscript Submission
SCHOLAR ONE

ViH Call for Papers

Call for Papers: HTA

ViH Access on Elsevier Site ISPOR Members Non-member
Value in Health
Paper of the Year Award

Richard Cookson, PhD Richard Cookson, PhD, Centre for Health Economics, University of York, York, UK, is the winner of the 2018 ISPOR Paper of the Year Award

Using Cost-Effectiveness Analysis to Address Health Equity Concerns, Value in Health, 2017;20(2):206-212.

View Award Information »

ISPOR Career Center


Latest Tweet
Value in Health Co-Editors-in-Chief
Michael Drummond, DPhil and C. Daniel Mullins, PhD discuss their goals for the journal's future